Utah Medical Products (UTMD) EBIT (2010 - 2026)

Utah Medical Products' EBIT history runs 17 years deep, the most recent figure standing at $2.6 million for Q1 2026.

• In Q1 2026, EBIT fell 18.65% year-over-year to $2.6 million; the TTM figure through Mar 2026 stood at $1.9 million (down 85.32% YoY), while the FY2025 annual figure was $2.5 million, down 11.35% from the prior year.
• EBIT was $2.6 million for Q1 2026 at Utah Medical Products, up from -$6.5 million in the prior quarter.
• In the past five years, EBIT ranged from a high of $5.1 million in Q3 2022 to a low of -$12.1 million in Q4 2022.
• Historically, EBIT has averaged $1.4 million across 5 years, with a median of $3.3 million in 2024.
• The sharpest annual moves came in 2022 and 2024: EBIT tumbled 335.87% in 2022, then soared 127.94% in 2024.
• A 5-year view of EBIT shows it stood at -$12.1 million in 2022, then increased by 13.33% to -$10.5 million in 2023, then jumped by 127.94% to $2.9 million in 2024, then slumped by 321.3% to -$6.5 million in 2025, then soared by 139.56% to $2.6 million in 2026.
• The last three EBIT figures came in at $2.6 million (Q1 2026), -$6.5 million (Q4 2025), and $2.6 million (Q3 2025), per Business Quant data.